Efficacy and Mechanism Evaluation programme - Logo

Commissioned remit

Quicklinks
 New funding stream for translational medicine
 Apply for Funding
The researcher-led workstream is currently open for outline applications.  This call will close at 1pm on 17 July 2012.
 Get Involved
Find out how to get involved with our work
 Resources
Useful links, FAQs and information to help with applications
 Join our mailing list
Latest News
 Treating severe fatigue in primary billary cirrhosis
 Lung volume reduction in COPD
 Provisional 2012 Commissioned Research Calls Announced
rss EME News Feed
twitter icon Follow NIHR on Twitter
 

 

Valid XHTML 1.0 Transitional

 

Plain English Campaign

 you are here › HomeAbout EME Commissioned workstream remit


The EME commissioned workstream is funded by the NIHR with contributions from the CSO in Scotland and NISCHR in Wales and the HSC R&D, Public Health Agency in Northern Ireland.

The EME commissioned workstream will fund large, often staged, projects which are of benefit to patients and the NHS. Proposals may include pilot and feasibility studies and late development of technologies.

Proposals are expected to be in the form of a substantial collaboration with at least two of the following three partners: industry, NHS and academia.

The remit of the EME commissioned workstream includes clinical trials and evaluative studies, in patients, which:

  • evaluate clinical efficacy of interventions;
  • add significantly to our understanding of biological or behavioural mechanisms and processes;
  • explore new scientific or clinical principles;
  • include the development or testing of new methodologies.

The EME commissioned workstream WILL support:

  • research which seeks to determine definitive proof of clinical efficacy and size of effect, safety and possibly effectiveness;
  • studies that use validated surrogate markers as indicators of health outcome;
  • laboratory based, or similar, studies that are embedded within the main study, if relevant to the remit of the EME programme.


The EME commissioned workstream WILL NOT support:

  • confirmatory studies or trials of incremental modifications and refinements to existing medical interventions;
  • 'confidence in effect' studies;
  • research into 'global health', where 'global health' can be defined as 'areas where the health need is identified in developing countries (i.e. including diseases of developing countries), or where the health need does not yet exist in the UK but might in the future and the problem can be best addressed in developing countries';
  • research involving animals.


The EME commissioned workstream will support research proposals which are important to healthcare, from researchers based across the UK (England, Scotland, Wales and Northern Ireland).

 printer friendly version   share Share

The Efficacy and Mechanism Evaluation programme is funded by the MRC and NIHR, with contributions from the CSO in Scotland and NISCHR in Wales and the HSC R&D, Public Health Agency in Northern Ireland. It is managed by the NIHR Evaluation, Trials and Studies Coordinating Centre (NETSCC) based at the University of Southampton.

University of Southampton - Logo